Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

Support Care Cancer
10 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/35001215/

 

The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)

Low-Dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study

Neuro Oncol
November 2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639177/

Subscribe to Glioma